enGene Holdings Inc. - Common Shares (ENGN)

CUSIP: 29286M105

Q4 2023 13F Holders as of 31 Dec 2023

Holder snapshot 5 signals
Share change
+5,509,913
SEC-reported price per share
$9.23
Indexed holders
11
Value change
+$50,843,719
Number of buys
10
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
69,067,097

Security key

29286M105

Report period

Q4 2023

Indexed institutions

11

Top holders

9

Ownership snapshot

Top reported holders of ENGN - enGene Holdings Inc. - Common Shares (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Forbion Growth Sponsor FE...
Disclosed value leader
—
Comparable rows
0/6
Latest evidence
30 Nov 2023
3/4/5 Some rows are evidence-backed but not safely comparable across classes. 6 rows are not safely comparable across share classes.

Quick read

SEC ownership evidence is available, but the rows are not safely comparable across share classes.

0 of 6 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Forbion Growth Sponsor FEAC I B.V.'s linked filing trail.
Detailed SEC evidence table Showing 1-6 of 6 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Forbion Growth Sponsor FEAC I B.V.
3/4/5
10%+ Owner
—
mixed-class rows
—
5,502,338 shares
mixed-class rows
— 31 Oct 2023
Forbion Capital Fund III Cooperatief U.A.
3/4/5
10%+ Owner
—
denominator unverified
—
2,894,735 shares
— 31 Oct 2023
BVF PARTNERS L P/IL
3/4/5
10%+ Owner
—
denominator unverified
—
104,257 shares
— 31 Oct 2023
Jason David Hanson
3/4/5
Chief Executive Officer, Director
—
denominator unverified
—
512,826 shares
— 31 Oct 2023
Richard P. Bryce
3/4/5
Chief Medical Officer
—
denominator unverified
—
153,000 shares
— 30 Nov 2023
James C. Sullivan
3/4/5
Chief Scientific Officer
—
denominator unverified
—
118,509 shares
— 31 Oct 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
11
Shares
14,187,864
Indexed holders
11
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q4 2023 vs Q2 2026 Across Filers

Q2 2026 indexed holders
5
Q4 2023 indexed holders
11
Indexed holder difference
6
Investor Q2 2026 Shares Q4 2023 Shares Share Diff Share Chg % Q2 2026 value Q4 2023 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .